Results: 14

A simple method for the quantification of diclofenac potassium in oral suspension by high-performance liquid chromatography with UV-detection

Braz. j. pharm. sci; 49 (3), 2013
A rapid, simple and low cost method was developed to determine diclofenac potassium (DP) in oral suspension, using a reverse-phase column (C8, 150 mm x 4.6 mm, 5 µm), mobile phase containing methanol/buffer phosphate (70:30 v/v, pH 2.5), at a flow rate of 1.0 mL/min, isocratic method, and ultraviolet de...

Formulation and evaluation of buccoadhesive quetiapine fumarate tablets

Braz. j. pharm. sci; 48 (2), 2012
The aim of present study was to develop and evaluate buccoadhesive Quetiapine Fumarate (QF) tablets, which is extensively metabolised by liver. Buccoadhesive tablets of QF were prepared using HPMC K4M, HPMC K15M and combination of carbopol and HPC as mucoadhesive polymers by direct compression method. So...

Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant

Braz. j. pharm. sci; 48 (4), 2012
The present study was undertaken to develop sustained release (SR) matrix tablets of losartan potassium, an angiotensin-II antagonist for the treatment of hypertension. The tablets were prepared by direct compression method, along with Kollidon SR as release retardant polymer. The amount of losartan pota...

Formulation and in vitro evaluation of taste-masked oro-dispersible dosage form of diltiazem hydrochloride

Braz. j. pharm. sci; 47 (4), 2011
Diltiazem hydrochloride is a calcium channel blocker generally indicated for the treatment of angina and hypertension, and it is extensively metabolized due to the hepatic metabolism. Formulation of diltiazem hydrochloride into an oro-dispersible dosage form can provide fast relief with higher bioavailab...